|
|
Volumn 82, Issue 4, 1999, Pages 399-401
|
|
Infarct angioplasty: Editorial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
STREPTOKINASE;
ANGIOPLASTY;
COST EFFECTIVENESS ANALYSIS;
EDITORIAL;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
MORTALITY;
PRIORITY JOURNAL;
REVASCULARIZATION;
SALVAGE THERAPY;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
EMERGENCY;
EMERGENCY HEALTH SERVICE;
ORGANIZATION AND MANAGEMENT;
PATIENT SELECTION;
PUBLIC HOSPITAL;
TRANSLUMINAL CORONARY ANGIOPLASTY;
UNITED KINGDOM;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
EMERGENCIES;
EMERGENCY SERVICE, HOSPITAL;
GREAT BRITAIN;
HOSPITALS, DISTRICT;
HUMANS;
MYOCARDIAL INFARCTION;
PATIENT SELECTION;
THROMBOLYTIC THERAPY;
|
|
EID: 0033209758
PISSN: 13556037
EISSN: None
Source Type: Journal
DOI: 10.1136/hrt.82.4.399 Document Type: Editorial |
|
Times cited : (4)
|
|
References (15)
|
